Catalyst Wire Dossier Catalyst Wire Dossier

TB-402

· ThromboGenics
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TB-402, covering 2012-08-23 to 2014-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery [Phase 2]

See pricing